Suppr超能文献

普通儿科诊所中由药剂师管理的短效β受体激动剂续方服务。

Pharmacist-managed short-acting beta agonist refill service in a general pediatric clinic.

作者信息

Gildon Brooke L, John Barnabas, Condren Michelle, Keast Shellie, Maglunog Roxanne, Johnson Jeremy L, Robertson Christopher

出版信息

J Am Pharm Assoc (2003). 2018 May-Jun;58(3):296-302. doi: 10.1016/j.japh.2018.01.002. Epub 2018 Feb 3.

Abstract

OBJECTIVES

To use a pharmacist-managed short-acting beta agonist (SABA) service (1) to determine the patient's rationale for SABA refill requests, (2) to assess adherence to current controller therapy and current level of disease control, and (3) to characterize the pharmacist's recommendations made in response to a patient's SABA refill request.

SETTING

An academic-based general pediatric clinic.

PRACTICE DESCRIPTION

SABA overuse is a marker of increased morbidity and mortality in children with asthma. This article describes a pharmacist-managed SABA refill telephone service.

PRACTICE INNOVATION

The pediatric ambulatory care pharmacy team assessed and authorized (or denied) all SABA refill requests, provided education, and facilitated appropriate follow-up using a telephone service.

INTERVENTIONS

Upon receiving a patient-requested SABA refill, the pharmacist identified the reason for the SABA request, assessed asthma control, and determined adherence to daily controllers or spacer use, if applicable. Education was also provided. Data obtained were used to determine SABA refill approval.

EVALUATION

Primary reasons for SABA refill request were for (1) current symptom management and (2) no refills remaining in the absence of symptoms. Forty-two (50%) SABA refill requests were eligible for refill per the clinic algorithm, yet 70% actually received a refill after assessment by the pharmacist. Asthma control was assessed as 26% well controlled, 38% not well controlled, and 36% very poorly controlled. Forty-eight percent of patients prescribed daily controller medications were deemed adherent. Spacers were used in 43 of 76 (56%) patients using metered dose inhalers. Education was provided to 82% of caregivers. Pharmacists facilitated asthma follow-up visits in 41 of 84 (49%) patients contacted, and 61% of those appointments were kept.

CONCLUSIONS

Pharmacist management of a SABA refill telephone service provides an additional means for delivery of asthma education, facilitates follow-up asthma care, helps to identify patients at risk for increased morbidity and mortality due to the overuse of SABAs, and provides another mechanism for medication refills.

摘要

目的

利用药剂师管理的短效β受体激动剂(SABA)服务(1)确定患者SABA续方请求的理由,(2)评估对当前控制治疗的依从性和当前疾病控制水平,以及(3)描述药剂师针对患者SABA续方请求所提出的建议。

背景

一家以学术为基础的普通儿科诊所。

实践描述

SABA过度使用是哮喘儿童发病率和死亡率增加的一个标志。本文描述了一项由药剂师管理的SABA续方电话服务。

实践创新

儿科门诊护理药房团队评估并批准(或拒绝)所有SABA续方请求,提供教育,并通过电话服务促进适当的随访。

干预措施

收到患者要求的SABA续方后,药剂师确定SABA请求的原因,评估哮喘控制情况,并确定对每日控制药物或适用时对储物罐使用的依从性。还提供了教育。所获得的数据用于确定SABA续方批准情况。

评估

SABA续方请求的主要原因是(1)当前症状管理和(2)无症状时无剩余续方。根据诊所算法,42例(50%)SABA续方请求符合续方条件,但经药剂师评估后,70%的请求实际获得了续方。哮喘控制情况评估为26%控制良好,38%控制不佳,36%控制极差。48%的每日服用控制药物的患者被认为依从性良好。76例使用定量吸入器的患者中有43例(56%)使用了储物罐。82%的护理人员接受了教育。药剂师为84例(49%)联系的患者中的41例促进了哮喘随访就诊,其中61%的预约得到了遵守。

结论

药剂师对SABA续方电话服务的管理提供了一种额外的哮喘教育传播方式,促进了哮喘后续护理,有助于识别因过度使用SABA而有发病率和死亡率增加风险的患者,并提供了另一种药物续方机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验